Transplantation of cell sheets from adipose-derived mesenchymal stromal cells effectively induces angiogenesis in ischemic skeletal muscle


Cite item

Full Text

Abstract

Delivery of cells is a promising approach to induce blood vessel formation for treatment of ischemia. Still, efficacy of these methods has been shown to be below expectations due to the fact that injection procedures used to transplant cells can diminish their survival rate. To circumvent this problem a technique known as “cell sheets” can be utilized. Cell sheets are minimal tissue-engineered constructs that comprise of cells along with their extracellular matrix proteins Present study investigates application of cell sheets from adipose-derived mesenchymal stromal cells (AD-MSC) to stimulate angiogenesis. In a mouse model of limb ischemia we demonstrate that subcutaneous implantation of a cell sheet from 1 mln AD-MSC effectively stimulates angiogenesis and restores perfusion of ischemic muscle compared to untreated animals with limb ischemia. Histology also indicates that cell sheet transplantation results in decreased necrosis of skeletal muscle and retain of AD-MSC at Day 14 with certain prevalence of proliferating and minimal amount of apoptotic cells within cell sheet Furthermore, comparison of cell sheet-treated animals vs. injection of the same dose of AD-MSC shows that cell sheet delivery was superior to routine injection-based delivery in terms of limb perfusion and tissue protection Obtained results indicate that local application of AD-MSC cell sheets to promote angiogenesis and protect skeletal muscle from ischemia can be a promising approach for therapeutic use

Full Text

Restricted Access

About the authors

P. I Makarevich

Email: pmakarevich@mc.msu.ru
Institute of experimental cardiology, Russian cardiology research and production complex Moscow, Russia

M. A Boldyreva

Institute of experimental cardiology, Russian cardiology research and production complex Moscow, Russia

K. V Dergilev

Institute of experimental cardiology, Russian cardiology research and production complex Moscow, Russia

E. V Gluhanyuk

M.V. Lomonosov Moscow state university Moscow, Russia

J. O Gallinger

M.V. Lomonosov Moscow state university Moscow, Russia

A. Yu Efimenko

M.V. Lomonosov Moscow state university Moscow, Russia

V. A Tkachuk

M.V. Lomonosov Moscow state university Moscow, Russia

Ye. V Parfyonova

Institute of experimental cardiology, Russian cardiology research and production complex Moscow, Russia

References

  1. Myers T. J., Granero-Molto F., Longobardi L. et al., Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin. Biol. Ther. 2010; 10(12): 1663-79.
  2. Bourin P., Bunnell B.A., Casteilla L. et al., Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) . Cytotherapy 2013; 15(6): 641-8
  3. Fischer L.J., McIlhenny S., Tulenko T. et al., Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J. Surg. Res. 2009; 152(1): 157-66.
  4. Hong S. J., Traktuev D.O., March K.L. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair Curr Opin. Organ Transplant. 2010; 15(1): 86-91.
  5. Efimenko A.Y., Kochegura T.N., Akopyan Z.A. et al. Autologous stem cell therapy: how aging and chronic diseases affect stem and progenitor cells. BioResearch Open Access 2015; 4(1): 26-38.
  6. Huang S.J., Fu R.H., Shyu W.C. et al. Adipose-derived stem cells: isolation, characterization, and differentiation potential. Cell Transplant. 2013; 22(4): 701-9.
  7. Kim E.H., Heo C.Y., Current applications of adipose-derived stem cells and their future perspectives. World J. Stem Cells 2014; 6(1): 65-8.
  8. Suzuki E., Fujita D., Takahashi M. et al. Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease World J. Cardiol. 2015; 7(8): 454-65.
  9. Benoit E., O'Donnell T. F., Patel A.N. Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review. Cell Transplant. 2013; 22(3): 545-62.
  10. Hoefer I.E., van Royen N., Buschmann I.R. et al. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res. 2001; 49(3): 609-17.
  11. Karoubi G., Ormiston M.L., Stewart D.J. et al. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials 2009; 30(29): 5445-55.
  12. Aguado B.A., Mulyasasmita W., Su J. et al., Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. Part A 2012; 18(7-8): 806-15.
  13. Liu X.H., Bai C.G., Xu Z.Y. et al. Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. Microvasc. Res. 2008; 76(1): 23-30
  14. Zubkova E. S., Beloglazova I. B., Makarevich P. I. et al. Regulation of Adipose Tissue Stem Cells Angiogenic Potential by Tumor Necrosis Factor-Alpha. J. Cell Biochem. 2015; doi: 10. 1002/jcb. 25263.
  15. Elloumi-Hannachi I., Yamato M., Okano T. Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. J. Intern. Med. 2010; 267(1): 54-70.
  16. Yamato M., Utsumi M., Kushida A. et al. Thermo-responsive culture dishes allow the intact harvest of multilayered keratinocyte sheets without dispase by reducing temperature. Tissue Eng. 2001; 7(4): 473-80.
  17. Yeh T.S., Fang Y.H., Lu C.H. et al. Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction. Biomaterials 2014; 35(1): 174-84.
  18. Makarevich P., Tsokolaeva Z., Shevelev A. et al. Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. PLoS One 2012; 7(6): e38776.
  19. Boldyreva M.A., Makarevich P.I., Rafieva L.M. et al. Deliver of nerve growth factor (NGF) gene via recombinant plasmid vector induces angiogenesis in murine ischemic hind limb Genes and Cells 2014; 9(4): 81-87.
  20. Shevchenko E.K., Makarevich P.I., Tsokolaeva Z.I. et al. Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle. J. Transl. Med. 2013; 11: 138.
  21. Sanchez P.L., Fernandez-Santos M.E., Costanza S. et al. Acellular human heart matrix: A critical step toward whole heart grafts. Biomaterials 2015; 61: 279-89.
  22. Gubareva E.A., Sjoqvist S., Gilevich I.V. et al. Orthotopic transplantation of a tissue engineered diaphragm in rats Biomaterials 2015; 77: 320-35.
  23. Sekine H., Shimizu T., Dobashi I. et al. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection Tissue Eng Part A 2011; 17(23-24): 2973-80.
  24. Makarevich P. I., Dergilev K.V., Tsokolaeva Z.I. et al. Delivery of Genetically Engineered Adipose-Derived Cell Sheets for Treatment of Ischemic Disorders-Development of Application in Animal Models. In molecular therapy. 2015. Nature publishing group, NY 10013-1917 USA
  25. Tatsumi K., Sugimoto M., Lillicrap D. et al. A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia A. PLoS One 2013; 8(12): e83280.
  26. Lin C.Y., Lin K.J., Li K.C. et al. Immune responses during healing of massive segmental femoral bone defects mediated by hybrid baculovirus-engineered ASCs. Biomaterials 2012; 33(30): 7422-34
  27. Asakawa N., Shimizu T., Tsuda Y. et al. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering Biomaterials 2010; 31(14): 3903-9.
  28. Sekiya S., Shimizu T., Yamato M. et al. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential Biochem Biophys Res. Commun. 2006; 341(2): 573-82.
  29. Badylak S.F. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl. Immunol. 2004; 12(3-4): 367-77.
  30. Zhang M., Guo R., Shi S. et al. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy. PLoS One 2014; 9(3): e92326.
  31. Lopatina T., Kalinina N., Karagyaur M. et al. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS One 2011; 6(3): e17899.
  32. Shireman P.K., Quinones M.P. Differential necrosis despite similar perfusion in mouse strains after ischemia J Surg Res 2005; 129(2): 242-50.
  33. Asahara T., Bauters C., Zheng L.P. et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995; 92(9 Suppl): II365-71.
  34. Weber M.A., Krakowski-Roosen H., Delorme S. et al. Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density J Ultrasound Med. 2006; 25(5): 583-91.

Copyright (c) 2015 PJSC Human Stem Cells Institute


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 57156 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies